Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,480Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Changzhou Qianhong Bio-Pharma
    China
    		 Hanlim Pharmaceutical Co., Ltd. 20100331-124-G-29-02(2) heparin sodium 2011-04-14 Changzhou Qianhong Bio Pharma co.,Ltd. China No. 192 Huangche west Road, Xinbei District Changzhou, Jiangsu China
    29/11/2025 Changzhou Qianhong Bio-Pharma
    China
    		 Mertz Asia Pacific PT.E.L.D. 20100331-124-G-29-02(8) heparin sodium 2017-12-08 Changzhou Qianhong Bio Pharma Co., Ltd China No. 192 Huanghe West Road, Xinbei District, Changzhou, Jiangsu